TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Magnus Nylander Biocare AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
5
|
8
|
24 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
0
|
-31
|
8 |
| EBITDA |
-1
|
-31
|
3 |
| Total assets |
35
|
67
|
76 |
| Current assets |
33
|
65
|
73 |
| Current liabilities |
23
|
54
|
28 |
| Equity capital |
12
|
13
|
47 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
1
|
1
|
0 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
34.3%
|
19.4%
|
61.8% |
| Turnover per employee |
5
|
8 | |
| Profit as a percentage of turnover |
0%
|
-387.5%
|
33.3% |
| Return on assets (ROA) |
0%
|
-46.3%
|
10.5% |
| Current ratio |
143.5%
|
120.4%
|
260.7% |
| Return on equity (ROE) |
0%
|
-238.5%
|
17.0% |
| Change turnover |
-4
|
-14
|
-7 |
| Change turnover % |
-43%
|
-63%
|
-21% |
| Chg. No. of employees |
0
|
1
|
-1 |
| Chg. No. of employees % | 0% | -100% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.